Quantbot Technologies LP Sells 125,947 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Quantbot Technologies LP trimmed its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 81.5% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,644 shares of the medical instruments supplier’s stock after selling 125,947 shares during the quarter. Quantbot Technologies LP’s holdings in DENTSPLY SIRONA were worth $775,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of XRAY. First Eagle Investment Management LLC boosted its stake in shares of DENTSPLY SIRONA by 33.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after purchasing an additional 3,283,965 shares during the period. Nuance Investments LLC boosted its position in shares of DENTSPLY SIRONA by 3.8% during the second quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock valued at $271,019,000 after buying an additional 402,329 shares during the period. FMR LLC grew its stake in shares of DENTSPLY SIRONA by 5.1% during the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock valued at $245,076,000 after buying an additional 436,031 shares during the last quarter. Cooke & Bieler LP raised its holdings in shares of DENTSPLY SIRONA by 16.2% in the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after buying an additional 1,046,105 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in shares of DENTSPLY SIRONA by 42.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after acquiring an additional 1,308,411 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

XRAY has been the topic of several research analyst reports. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Needham & Company LLC cut their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Barrington Research lowered their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Finally, Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Seven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $29.50.

DENTSPLY SIRONA Trading Up 0.1 %

NASDAQ XRAY opened at $19.65 on Monday. The company’s 50-day simple moving average is $22.55 and its two-hundred day simple moving average is $24.74. DENTSPLY SIRONA Inc. has a one year low of $17.21 and a one year high of $37.60. The company has a market capitalization of $3.91 billion, a price-to-earnings ratio of -9.49, a price-to-earnings-growth ratio of 1.93 and a beta of 1.02. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. DENTSPLY SIRONA’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.49 earnings per share. Equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.